Follow us

Bioventix (BVXP)

Bioventix (BVXP) ShareSoc presentation October 2018

15 October 2018

Bioventix ShareSoc presentation: October 2018
By Peter Harrison, CEO.

Includes full year results year ended 30th June 2018.

Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing. The Company’s non-vitamin D business consists of antibodies, NT proBNP (heart failure), testosterone, Free Triiodothyronine (FT3) (thyroid hormone), estradiol, and various drugs, such as tetrahydrocannabinol (THC)/cannabis, and progesterone. The Company offers products for indications, such as thyroid, fertility, oncology, cardiac, vitamin D, drug of abuse, infectious disease and miscellaneous. Its sheep hybridoma technology produces cell lines that secrete SMAs. The Company offers a panel of SMAs to 25-OH D and has various 25-OH D2 and 25-OH D3 specific antibodies. It sells its products through direct sales and through distributors.


Overview – 00:29
Location and skills – 00:54
Automated blood testing – 01:26
Creating antibodies – 05:35
Why SMA’s? (Testosterone) – 07:49
Why SMA’s? (Troponin) – 10:04
Financial highlights 17/18 – 12:00
BVXP sales 17/18 product mix – 12:58
Key financials – 14:50
New Troponin assays – 15:46
Pipeline Development 2018 – 16:18
Business dynamics – 18:40
Selected shareholder base – 22:05
Bioventix Directors – 22:42
Conclusion and outlook – 23:19
Q&A – 24:39


The presentation slides can be viewed here.


Listen on the go


PIWORLD provides investors with the latest news and insight about listed companies and their management through either live or recorded investor presentations, management interviews, Capital Market Days and corporate overviews, together with interviews with leading fund managers or esteemed private investors in the small cap world.

Our Services

PIWORLD delivers high quality audio and video content to present anything from full-year & interim results to Capital Markets Days and corporate overviews. We bridge the gap between listed companies and the private investor community, who drive the share price and provide liquidity, providing a time and cost effective medium to reach this diverse and important audience.